Recombinant multi-species HIP14/ZDHHC17 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HIP14/ZDHHC17 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables identical protein binding activity and protein-cysteine S-palmitoyltransferase activity. Involved in lipoprotein transport and protein palmitoylation. Located in Golgi membrane; Golgi-associated vesicle membrane; and aggresome. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: A230053P19Rik,Acyltransferase ZDHHC17,D130071N24Rik,DHHC domain-containing cysteine-rich protein 17 (DHHC17),DHHC-17,DHHC17,HIP14,HIP3,HSPC294,HYPH,Hip14,Huntingtin yeast partner H,Huntingtin-interacting protein 14 (HIP-14),Huntingtin-interacting protein 3 (HIP-3),Huntingtin-interacting protein H,Palmitoyltransferase ZDHHC17,Putative MAPK-activating protein PM11,Putative NF-kappa-B-activating protein 205,ZDHHC17,Zdhhc17,Zinc finger DHHC domain-containing protein 17

Target products collectionGo to HIP14/ZDHHC17 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2304-Ag-1/ GM-Tg-hg-IP2304-Ag-2 Human HIP14/ZDHHC17 protein Human
GM-Tg-rg-IP2304-Ag-1/ GM-Tg-rg-IP2304-Ag-2 Rat HIP14/ZDHHC17 protein Rat
GM-Tg-mg-IP2304-Ag-1/ GM-Tg-mg-IP2304-Ag-2 Mouse HIP14/ZDHHC17 protein Mouse
GM-Tg-cynog-IP2304-Ag-1/ GM-Tg-cynog-IP2304-Ag-2 Cynomolgus/Rhesus macaque HIP14/ZDHHC17 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2304-Ag-1/ GM-Tg-felg-IP2304-Ag-2 Feline HIP14/ZDHHC17 protein Feline
GM-Tg-cang-IP2304-Ag-1/ GM-Tg-cang-IP2304-Ag-2 Canine HIP14/ZDHHC17 protein Canine
GM-Tg-bovg-IP2304-Ag-1/ GM-Tg-bovg-IP2304-Ag-2 Bovine HIP14/ZDHHC17 protein Bovine
GM-Tg-equg-IP2304-Ag-1/ GM-Tg-equg-IP2304-Ag-2 Equine HIP14/ZDHHC17 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2304-Ag-1/ GM-Tg-hg-IP2304-Ag-2; GM-Tg-rg-IP2304-Ag-1/ GM-Tg-rg-IP2304-Ag-2;
GM-Tg-mg-IP2304-Ag-1/ GM-Tg-mg-IP2304-Ag-2; GM-Tg-cynog-IP2304-Ag-1/ GM-Tg-cynog-IP2304-Ag-2;
GM-Tg-felg-IP2304-Ag-1/ GM-Tg-felg-IP2304-Ag-2; GM-Tg-cang-IP2304-Ag-1/ GM-Tg-cang-IP2304-Ag-2;
GM-Tg-bovg-IP2304-Ag-1/ GM-Tg-bovg-IP2304-Ag-2; GM-Tg-equg-IP2304-Ag-1/ GM-Tg-equg-IP2304-Ag-2
Products Name HIP14/ZDHHC17 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HIP14/ZDHHC17
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HIP14/ZDHHC17 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.